CDER - Office of Compliance - Organization - Text Version

The following header reflects the organizational hierarchy.

FOOD AND DRUG ADMINISTRATION
OFFICE OF MEDICAL PRODUCTS AND TOBACCO
CENTER FOR DRUG EVALUATION AND RESEARCH
OFFICE OF COMPLIANCE

The following is the communication box containing information to assist anyone who may want to communicate with the depicted organization via telephone, facsimile or mail.

Main Tele:     301-796-3100
Fax:               301-847-8747
Address:        WO Bldg 51 Rm: 5270
                      10903 New Hampshire Ave.
                      Silver Spring, MD 20993

The following is the Food and Drug Administration, Office of Medical Products and Tobacco, Center for Drug Evaluation and Research, Office of Compliance organization structure depicting all the organizational structures reporting to the Office Director.  These organizational structures are organized in sequential order by their assigned Standard Administrative code (Alphanumeric sequence of characters beginning with the letter D).

Each organizational component will be depicted in the following standard format:

Title of organization.
Position title of the manager.
Military rank if any, first name, middle initial if any, last name, post graduate degrees if any, and if the individual is designated as acting.
Standard Administrative code.

DIRECTOR
Howard Sklamberg

Reports Directly to the Director:

DEPUTY DIRECTOR
Ilisa Bernstein, Pharm.D., J.D.

DEPUTY DIRECTOR PROGRAM OPERATIONS
Michael Levy (Acting)

DEPUTY DIRECTOR POLICY AND ANALYSIS
Douglas Stern, Esq. (Acting)
(DKKND)

OFFICE OF MANUFACTURING AND PRODUCT QUALITY
DIRECTOR
Steven Lynn

Reports Directly to the Director, Office of Manufacturing and Product Quality:

DEPUTY DIRECTOR
Michael Smedley
(DKKNDA)

Reports Directly to the Director:

OFFICE OF UNAPPROVED DRUGS AND LABELING COMPLIANCE
DIRECTOR
Kathleen Anderson (Acting)

Reports Directly to the Director, Office of Unapproved Drugs and Labeling Compliance:

DEPUTY DIRECTOR
Kathleen Anderson
(DKKNDD)

Reports Directly to the Director:

OFFICE OF DRUG SECURITY,INTEGRITY, AND RECALLS
DIRECTOR
Thomas J. Christl (Acting)

Reports Directly to the Director, Office of Drug Secrity, Integrity, and Recalls:

DEPUTY DIRECTOR
Thomas J. Christl
(DKKNDF)

Reports Directly to the Director:

OFFICE OF SCIENTIFIC INVESTIGATIONS
DIRECTOR
Thomas Moreno (Acting)

Reports Directly to the Director, Office of Scientific Investigations:

DEPUTY DIRECTOR
Thomas Moreno
(DKKNDE)

Approved by the FDA Reorganization Coordinator and Principal Delegations Control Officer